Results 41 to 50 of about 1,888 (198)
Iraqi Journal of Pharmaceutical SciencesLornoxicam (LOX) is a potent nonsteroidal anti-inflammatory drug (NSAID) oxicam class; that can be used into treat ocular inflammation; when applied locally to the eye, reducing systemic side effects.
Riyam Sadiq Jaffer, Hanan Jalal Kassab
doaj +1 more source
Eurasian Journal of Medicine, 2019 Objective: In this study, we aimed comparing early postoperative period analgesic effectiveness and the effects on opioid consumption of intravenous dexketoprofen and lornoxicam that are given preemptively.
Gonul Sagiroglu
doaj +1 more source
Skin irritation study of optimized lornoxicam reservoir patch (mean ± SD;
, 2020 Skin irritation study of optimized lornoxicam reservoir patch (mean ± SD; = 6).
Muhammad Harris Shoaib (5706638) +3 more
core +1 more source
Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1371-1381, May 2026.The World Health Organization Model Essential Medicines List and African national essential medicines lists (EMLs) detail drugs intended to be consistently available within national health systems, thereby supporting clinicians and pharmacists in making evidence‐based treatment decisions.
Tinashe A. Mazhindu +5 more
wiley +1 more source
Effects of Omega-3 Co-Administered with Therapeutic Dose of lornoxicam on Male Rats' Liver
Iraqi Journal of Pharmaceutical Sciences, 2019 The purpose of this study was to investigate the effect of omega-3 poly unsaturated fatty-acids co-administered with the therapeutic dose of lornoxicam on liver of healthy rats.
Israa A. Majeed, Nada N. Al-Shawi
doaj +1 more source
Macrophage‐Targeting Biomaterials for Osteoarthritis Therapy
Journal of Biomedical Materials Research Part A, Volume 114, Issue 5, May 2026.Macrophage‐Targeting Biomaterials for Osteoarthritis Therapy. Created in BioRender. Jain, E. (2026) https://BioRender.com/x4f9o8g. ABSTRACT Osteoarthritis (OA) is a highly prevalent, disabling, and painful disease of the joints, characterized by progressive cartilage degeneration, synovial fibrosis, and pain.
Era Jain, Paul Nana Kwame Sagoe
wiley +1 more source
A validated stability-indicating RP-HPLC method for paracetamol and lornoxicam: Application to pharmaceutical dosage forms [PDF]
Chemical Industry and Chemical Engineering Quarterly, 2014 A new method for the simultaneous determination of paracetamol (PR) and lornoxicam (LR) has been developed by reversed phase HPLC from the combination drug product.
Karunakaran Kulandaivelu +2 more
doaj +1 more source
FORMULATION AND DEVELOPMENT OF SUSTAINED RELEASE MATRIX TABLETS OF LORNOXICAM [PDF]
, 2018 Lornoxicam is a NSAID having oxicam class mainly prescribed in the treatment of osteoarthritis and rheumatoid arthritis. NSAID have the potential to relieve the pain and inflammation without the immunosuppressive and metabolic side effects associated ...
PAWAR, P A +9 more
core +1 more source
Matrix-mini-tablets of lornoxicam for targeting early morning peak symptoms of rheumatoid arthritis [PDF]
Iranian Journal of Basic Medical Sciences, 2014 Objective(s): The aim of present research was to develop matrix-mini-tablets of lornoxicam filled in capsule for targeting early morning peak symptoms of rheumatoid arthritis.
Abdul Hadi Mohd +2 more
doaj
Journal of Anaesthesiology Clinical Pharmacology, 2013 Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are valuable for post-operative pain as they reduce the use of opioids. Cyclooxygenase-2 inhibitors and traditional NSAIDs can be used. This is a prospective, randomized, placebo-controlled trial
Irene Kouroukli +5 more
doaj +1 more source